Dongxia Luo
Public Health Clinical Center of Chengdu(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Mycobacterium research and diagnosis, SARS-CoV-2 detection and testing, Tuberculosis Research and Epidemiology
Most-Cited Works
- → Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis(2017)190 cited
- → S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates(2021)162 cited
- Increased detectability of alpha brain glutamate/glutamine in neonatal hypoxic-ischemic encephalopathy.(2000)
- → Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice(2018)52 cited
- → Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD(2020)40 cited
- → On-site analysis of COVID-19 on the surfaces in wards(2020)22 cited
- → Drug resistance characteristics of Mycobacterium tuberculosis isolates obtained between 2018 and 2020 in Sichuan, China(2022)18 cited
- → Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate(2021)18 cited
- → Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus(2020)18 cited